ketoconazole has been researched along with Metabolic Syndrome in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blass, BE | 1 |
| Iyer, P | 1 |
| Abou-Gharbia, M | 1 |
| Childers, WE | 1 |
| Gordon, JC | 1 |
| Ramanjulu, M | 1 |
| Morton, G | 1 |
| Arumugam, P | 1 |
| Boruwa, J | 1 |
| Ellingboe, J | 1 |
| Mitra, S | 1 |
| Nimmareddy, RR | 1 |
| Paliwal, S | 1 |
| Rajasekhar, J | 1 |
| Shivakumar, S | 1 |
| Srivastava, P | 1 |
| Tangirala, RS | 1 |
| Venkataramanaiah, K | 1 |
| Yanamandra, M | 1 |
1 other study available for ketoconazole and Metabolic Syndrome
| Article | Year |
|---|---|
Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Female; Guinea Pigs; Humans; Ketoconazole; | 2016 |